HDLs protect pancreatic β-cells against ER stress by restoring protein folding and trafficking

Diabetes

Volumn 61, Issue 5, 2012, Pages 1100-1111

  Pétremand, Jannick ^a   Puyal, Julien ^a   Chatton, Jean Yves ^a   Duprez, Jessica ^b   Allagnat, Florent ^c   Frias, Miguel ^d   James, Richard W ^d   Waeber, Gérard ^c   Jonas, Jean Christophe ^b   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CYCLOPIAZONIC ACID; GLUCOSE; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; PALMITIC ACID; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN TRANSPORT; RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ENDOPLASMIC RETICULUM; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN-SECRETING CELLS; INSULINOMA; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MICE; MUTATION; PROTEIN FOLDING; PROTEIN TRANSPORT; RATS; RATS, WISTAR; STRESS, PHYSIOLOGICAL; VIRAL FUSION PROTEINS;

EID: 84860592286     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1221     Document Type: Article

References (49)

1. Eizirik DL, Cnop M. ER stress in pancreatic beta cells: the thin red line between adaptation and failure. Sci Signal 2010;3:pe7
2. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008;29:42-61 (Pubitemid 351252746)
3. Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002;7:335-345 (Pubitemid 34832258)
4. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54(Suppl. 2):S97-S107 (Pubitemid 43343337)
5. Elouil H, Bensellam M, Guiot Y, et al. Acute nutrient regulation of the unfolded protein response and integrated stress response in cultured rat pancreatic islets. Diabetologia 2007;50:1442-1452 (Pubitemid 46879004)
6. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529 (Pubitemid 46985379)
7. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002;109:525-532 (Pubitemid 34171784)
8. Huang CJ, Lin CY, Haataja L, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007;56:2016-2027 (Pubitemid 47201819)
9. Laybutt DR, Preston AM, Akerfeldt MC, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007;50:752-763 (Pubitemid 46355827)
10. Marchetti P, Bugliani M, Lupi R, et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 2007;50:2486-2494 (Pubitemid 350060637)
11. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984;25: 1017-1058
12. von Eckardstein A, Hersberger M, Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 2005;8:147-152 (Pubitemid 40289474)
13. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. J Clin Endocrinol Metab 2000;85:3101-3108
14. Montonen J, Drogan D, Joost HG, et al. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011;26:29-38
15. Laaksonen MA, Knekt P, Rissanen H, et al. The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol 2010;25:115-124
16. Kruit JK, Brunham LR, Verchere CB, Hayden MR. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Curr Opin Lipidol 2010;21:178-185
17. Ueda M, Hayase Y, Mashiba S. Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels. Clin Chim Acta 2007;378:105-111 (Pubitemid 46241068)
18. Nagano Y, Arai H, Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991;88:6457-6461 (Pubitemid 21914965)
19. Drew BG, Duffy SJ, Formosa MF, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 2009;119:2103-2111
20. Roehrich ME, Mooser V, Lenain V, et al. Insulin-secreting β-cell dysfunction induced by human lipoproteins. J Biol Chem 2003;278:18368-18375 (Pubitemid 36799458)
21. Cnop M, Hannaert JC, Grupping AY, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 2002;143:3449-3453 (Pubitemid 34925718)
22. Abderrahmani A, Niederhauser G, Favre D, et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic β cells. Diabetologia 2007;50:1304-1314 (Pubitemid 46701553)
23. Pétremand J, Bulat N, Butty AC, et al. Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells. Mol Endocrinol 2009;23:1572-1586
24. Rütti S, Ehses JA, Sibler RA, et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology 2009;150:4521-4530
25. Fryirs MA, Barter PJ, Appavoo M, et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 2010;30:1642-1648
26. Bulat N, Jaccard E, Peltzer N, et al. RasGAP-derived fragment N increases the resistance of beta cells towards apoptosis in NOD mice and delays the progression from mild to overt diabetes. PLoS ONE 2011;6:e22609
27. Lefrancois L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 1982;121:157-167 (Pubitemid 12047215)
28. Miyazaki J, Araki K, Yamato E, et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990;127:126-132 (Pubitemid 20228111)
29. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353
30. James RW, Pometta D. Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes 1990;39:1158-1164 (Pubitemid 20327049)
31. Zhang K, Kaufman RJ. Identification and characterization of endoplasmic reticulum stress-induced apoptosis in vivo. Methods Enzymol 2008;442:395-419
32. Presley JF, Cole NB, Schroer TA, Hirschberg K, Zaal KJ, Lippincott-Schwartz J. ER-to-Golgi transport visualized in living cells. Nature 1997;389:81-85 (Pubitemid 27387695)
33. Deakin S, Moren X, James RW. HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity. Arterioscler Thromb Vasc Biol 2007;27:1146-1152 (Pubitemid 46641970)
34. Wolff SP. Ferrous ion oxidation in the presence of the ferric ion indicator xylenol orange for the measure of hydroperoxydes: the FOX assay. Methods Enzymol 1994;233:182-189
35. Sambrook JF. The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell 1990;61:197-199
36. Pétremand J, Widmann C. Genetics and molecular biology: fatty acids and endoplasmic reticulum stress. Curr Opin Lipidol 2011;22:315-316
37. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 2001;50(Suppl. 1):S154-S159 (Pubitemid 32148243)
38. Nofer JR, Levkau B, Wolinska I, et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 2001;276:34480-34485
39. Nofer JR, van der Giet M, Tölle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004; 113:569-581 (Pubitemid 38542506)
40. Kimura T, Tomura H, Sato K, et al. Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells. J Biol Chem 2010;285:4387-4397
41. 2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells. Neurochem Int 2006;48:696-702
42. Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 1999;103:27-37 (Pubitemid 29031160)
43. Donaldson JG, Finazzi D, Klausner RD. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 1992;360:350-352 (Pubitemid 23000673)
44. Preston AM, Gurisik E, Bartley C, Laybutt DR, Biden TJ. Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia 2009;52:2369-2373
45. Pan B, Ren H, Ma Y, et al. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer. In press
46. Al-Jarallah A, Trigatti BL. A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochim Biophys Acta 2010;1801:1239-1248
47. von Eckardstein A, Sibler RA. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol 2011;22:26-32
48. Engin F, Hotamisligil GS. Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes Obes Metab 2010;12(Suppl. 2):108-115
49. Lilla V, Webb G, Rickenbach K, et al. Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinology 2003;144:1368-1379 (Pubitemid 36428479)